Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey E Teigler

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Virology|July 13, 2012
Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeysJeffrey E Teigler, M Justin Iampietro, Dan H Barouch
Journal of Virology|July 4, 2014
Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunityJeffrey E Teigler, Jonathan C Kagan, Dan H Barouch
Journal of Virology|November 22, 2013
The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeysJeffrey E Teigler, Sanjay Phogat, Genoveffa Franchini, et al.
Journal of Virology|July 20, 2012
Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeysHualin Li, Elizabeth G Rhee, Katherine Masek-Hammerman, et al.
Clinical and Vaccine Immunology : CVI|June 20, 2014
Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectorsJeffrey E Teigler, Pablo Penaloza-MacMaster, Rebecca Obeng, et al.
Journal of Virology|March 21, 2014
Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimensPablo Penaloza-MacMaster, Jeffrey E Teigler, Rebecca C Obeng, et al.
Journal of Virology|May 5, 2017
Preservation of Peripheral T Follicular Helper Cell Function in HIV ControllersSupranee Buranapraditkun, Franco Pissani, Jeffrey E Teigler, et al.
Immunity|January 23, 2016
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper FunctionsBruce T Schultz, Jeffrey E Teigler, Franco Pissani, et al.
Journal of Virology|September 15, 2017
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral InfectionJeffrey E Teigler, Gennadiy Zelinskyy, Michael A Eller, et al.
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Virology|July 13, 2012
Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeysJeffrey E Teigler, M Justin Iampietro, Dan H Barouch
Journal of Virology|July 4, 2014
Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunityJeffrey E Teigler, Jonathan C Kagan, Dan H Barouch
Journal of Virology|November 22, 2013
The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeysJeffrey E Teigler, Sanjay Phogat, Genoveffa Franchini, et al.
Journal of Virology|July 20, 2012
Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeysHualin Li, Elizabeth G Rhee, Katherine Masek-Hammerman, et al.
Clinical and Vaccine Immunology : CVI|June 20, 2014
Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectorsJeffrey E Teigler, Pablo Penaloza-MacMaster, Rebecca Obeng, et al.
Journal of Virology|March 21, 2014
Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimensPablo Penaloza-MacMaster, Jeffrey E Teigler, Rebecca C Obeng, et al.
Journal of Virology|May 5, 2017
Preservation of Peripheral T Follicular Helper Cell Function in HIV ControllersSupranee Buranapraditkun, Franco Pissani, Jeffrey E Teigler, et al.
Immunity|January 23, 2016
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper FunctionsBruce T Schultz, Jeffrey E Teigler, Franco Pissani, et al.
Journal of Virology|September 15, 2017
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral InfectionJeffrey E Teigler, Gennadiy Zelinskyy, Michael A Eller, et al.
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Pageof 2